References
- Silva RA, Berrocal AM, Moshfeghi DM, et al. Herpes simplex virus type 2 mediated acute retinal necrosis in a pediatric population: case series and review. Graefes Arch Clin Exp Ophthalmol. 2013;251:559–566. doi:https://doi.org/10.1007/s00417-012-2164-8.
- Donovan CP, Levison AL, Lowder CY, et al. Delayed recurrence of acute retinal necrosis (ARN): A case series. J Clin Virol. 2016;80:68–71. doi:https://doi.org/10.1016/j.jcv.2016.04.021.
- Muthiah MN, Michaelides M, Child CS, Mitchell SM. Acute retinal necrosis: a national population-based study to assess the incidence, methods of diagnosis, treatment strategies and outcomes in the UK. Br J Ophthalmol. 2007;91:1452–1455. doi:https://doi.org/10.1136/bjo.2007.114884.
- Lau CH, Missotten T, Salzmann J, Lightman SL. Acute retinal necrosis features, management, and outcomes. Ophthalmology. 2007;114:756–762. doi:https://doi.org/10.1016/j.ophtha.2006.08.037.
- Holland GN, Cornell PJ, Park MS, et al. An association between acute retinal necrosis syndrome and HLA-DQw7 and phenotype Bw62. DR4. 1989;108:370.
- Ichikaw T, Usui M. HLA antigens of patients with Kirisawa’s uveitis and herpetic keratiti. J Neurosci. 1989;9:851–864.
- von Hofsten J, Johnsson Forsberg M, Zetterberg M. Cytomegalovirus retinitis in a patient who received ruxolitinib. N Engl J Med. 2016;374:296–297. doi:https://doi.org/10.1056/NEJMc1413918.
- Haze M, Kobayashi T, Kakurai K, et al. Bilateral cytomegalovirus retinitis in a patient with systemic lupus erythematosus. Case Rep Ophthalmol. 2016;7:303–308. doi:https://doi.org/10.1159/000446391.
- Kezuka T, Sakai J, Usui N, et al. Evidence for antigen-specific immune deviation in patients with acute retinal necrosis. Arch Ophthalmol. 2001;119:1044–1049. doi:https://doi.org/10.1001/archopht.119.7.1044.
- Cathcart HM, Fields MA, Zheng M, et al. Infiltrating cells and IFNgamma production in the injected eye after uniocular anterior chamber inoculation of HSV-1. Invest Ophthalmol Vis Sci. 2009;50:2269–2275. doi:https://doi.org/10.1167/iovs.08-2874.
- Cathcart HM, Zheng M, Covar JJ, et al. Interferon-gamma, macrophages, and virus spread after HSV-1 injection. Invest Ophthalmol Vis Sci. 2011;52:3984–3993. doi:https://doi.org/10.1167/iovs.10-6449.
- Zheng M, Fields MA, Liu Y, et al. Neutrophils protect the retina of the injected eye from infection after anterior chamber inoculation of HSV-1 in BALB/c mice. Invest Ophthalmol Vis Sci. 2008;49:4018–4025. doi:https://doi.org/10.1167/iovs.08-1914.
- Fields MA, Zheng M, Wall P, et al. Uniocular anterior chamber inoculation of a tumor necrosis factor alpha-expressing recombinant of herpes simplex virus type 1 results in more rapid destruction and increased viral replication in the retina of the uninoculated eye. J Virol. 2008;82:5068–5078. doi:https://doi.org/10.1128/JVI.00082-08.
- Matsubara S, Atherton SS. Spread of HSV-1 to the suprachiasmatic nuclei and retina in T cell depleted BALB/c mice. J Neuroimmunol. 1997;80:165–171. doi:https://doi.org/10.1016/S0165-5728(97)00152-5.
- Holland GN. Standard diagnostic criteria for the acute retinal necrosis syndrome. Executive Committee of the American Uveitis Society. Am J Ophthalmol. 1994;117:663–667. doi:https://doi.org/10.1016/S0002-9394(14)70075-3.
- McGrath L, Woods M, Lee L, Conrad D. Acute retinal necrosis (ARN) in the context of neonatal HSV-2 exposure and subconjunctival dexamethasone: case report and literature review. Digit J Ophthalmol. 2013;19:28–32. doi:https://doi.org/10.5693/djo.02.2013.02.004.
- Bergstrom R, Gossman WG. Retinal Necrosis. In StatPearls. Treasure Island (FL): StatPearls Publishing StatPearls Publishing LLC; 2018.
- Grumach AS, Kirschfink M. Are complement deficiencies really rare? Overview on prevalence, clinical importance and modern diagnostic approach. Mol Immunol. 2014;61:110–117. doi:https://doi.org/10.1016/j.molimm.2014.06.030.
- de Visser L, de Boer JH, Rijkers GT, et al. Cytokines and chemokines involved in acute retinal necrosis. Invest Ophthalmol Vis Sci. 2017;58:2139–2151. doi:https://doi.org/10.1167/iovs.16-20799.
- Oxman MN. Zoster vaccine: current status and future prospects. Clin Infect Dis. 2010;51:197–213. doi:https://doi.org/10.1086/652976.
- Zhao Y, Shen WQ, Huang XW, et al. Detection of Th17 levels,treg cells and their related cytokines in patients with herpes zoster before and after the treatment. Chin J Derm Venereol. 2016;30:460–470. doi:https://doi.org/10.13735/j.cjdv.1001-7089.20151100.
- Sharma RK, Gupta A, Kamal S, et al. Role of regulatory T cells in tubercular uveitis. Ocul Immunol inflammation. 2016;26:1.
- Kim MS, Kim DJ, Na CH, Shin BS. A study of the changes of T helper 17 cells and regulatory T cells in herpes zoster. Ann Dermatol. 2017;29:578–585. doi:https://doi.org/10.5021/ad.2017.29.5.578.
- Runkle EA, Antonetti DA. The blood-retinal barrier: structure and functional significance. Methods Mol Biol. 2011;686:133–148.
- de Andrade FA, Fiorot SH, Benchimol EI, et al. The autoimmune diseases of the eyes. Autoimmun Rev. 2016;15:258–271. doi:https://doi.org/10.1016/j.autrev.2015.12.001.
- McPherson SW, Heuss ND, Pierson MJ, Gregerson DS. Retinal antigen-specific regulatory T cells protect against spontaneous and induced autoimmunity and require local dendritic cells. J Neuroinflammation. 2014;11:205. doi:https://doi.org/10.1186/s12974-014-0205-4.
- Barbi J, Pardoll D, Pan F. Treg functional stability and its responsiveness to the microenvironment. Immunol Rev. 2014;259:115–139. doi:https://doi.org/10.1111/imr.12172.
- Golebski K, Ros XR, Nagasawa M, et al. IL-1beta, IL-23, and TGF-beta drive plasticity of human ILC2s towards IL-17-producing ILCs in nasal inflammation. Nat Commun. 2019;10:2162. doi:https://doi.org/10.1038/s41467-019-09883-7.
- Lee HG, Lee JU, Kim DH, et al. Pathogenic function of bystander-activated memory-like CD4(+) T cells in autoimmune encephalomyelitis. Nat Commun. 2019;10:709. doi:https://doi.org/10.1038/s41467-019-08482-w.
- Shibata M, Sato T, Taguchi M, et al. [Analysis of cytokines related to helper T and regulatory t cells in the vitreous of uveitis patients]. Nippon Ganka Gakkai Zasshi. 2015;119:395–401.